All Press Releases for April 09, 2018

David R. Elmaleh Celebrates More than 40 Years of Professional Excellence in Pharmaceuticals

Dr. Elmaleh has been named for one of the 25 most valuable inventions for the decade of the Brain



    BOSTON, MA, April 09, 2018 /24-7PressRelease/ -- David R. Elmaleh, PhD, has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

An esteemed figure in the chemical and pharmaceutical industries, Dr. Elmaleh has accrued more than 40 years of clinical experience in his fields of expertise. Currently the chief executive officer and chair of AZTherapies, a company which develops drugs for Alzheimer's disease and other neurodegenerative diseases, Dr. Elmaleh was the cofounder of PureTech Ventures, cofounder of FluoroPharma, founder of Mersana Therapeutics, and founder of Molecular Insight Pharmaceuticals. Alongside his professional endeavors, Dr. Elmaleh is an associate professor at Harvard Medical School and director of contrast media chemistry at Massachusetts General Hospital.

In preparation for his celebrated career, Dr. Elmaleh first obtained a Bachelor of Science in physics and chemistry from the Hebrew University of Jerusalem. He followed this accomplishment at the same university, earning a Master of Science in physical and organic chemistry, as well as a Doctor of Philosophy in organic chemistry. He is renowned as a molecular imaging expert and inventor of molecular imaging agents. Additionally, he holds more than 90 patents and applications in the field, and he and his team delved into nuclear medicine, where they discovered that incipient plaque contributed to angina and other symptoms of atherosclerosis. The author and coauthor of more than 130 publications and chapters to books, Dr. Elmaleh maintains affiliation with several professional organizations. He is a member of the Society of Nuclear Medicine, the American Chemical Society, and the American Association for the Advancement of Science.

In recognition of his exceptional accomplishments, Dr. Elmaleh has been honored with several accolades throughout his impressive career. In 2014, he was inducted into Who's Who in Cambridge, MA. In addition, he was named as one of the biotechnology industry's 13 top serial entrepreneurs by Genetic Engineering & Biotechnology News. Dr. Elmaleh was nominated as one of the 25 most valuable inventors of the decade.

Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® now publishes many Who's Who titles, including Who's Who in America®, Who's Who in the World®, Who's Who in American Law®, Who's Who in Medicine and Healthcare®, Who's Who in Science and Engineering®, and Who's Who in Asia®. Marquis® publications may be visited at the official Marquis Who's Who® website at www.marquiswhoswho.com.

# # #

Contact Information

Fred Marks
Marquis Who's Who Ventures LLC
Berkeley Heights, NJ
USA
Voice: 844-394-6946
E-Mail: Email Us Here
Website: Visit Our Website
Follow Us: